https://www.thebodypro.com/author/myles-helfand

Latest by Myles Helfand

Promo Image
Neurocognitive

This Week in HIV Research: This Is Your Brain on (HIV) Drugs

NeuroAIDS while on efavirenz vs. common NRTIs; HIV and the smoking cessation aid varenicline; PrEP adherence after positive partners start treatment; and Ugandans underreporting their antiretroviral use.

This Week in HIV Research: Where's the PrEP? Img

This Week in HIV Research: Where's the PrEP?

This week: PrEP remains deeply underprescribed in North Carolina; and recent studies explore the effects of inflammation, age, and serum albumin on serious non-AIDS event risk.

This Week in HIV Research: To Seek and to Treat Img

This Week in HIV Research: To Seek and to Treat

This week: the successes of Vancouver's harm reduction and HIV outreach programs; the safety of stem-cell transplantation; how biomarkers predict health events; and how to improve partner notification.

This Week in HIV Research: A Viral Prediction Img

This Week in HIV Research: A Viral Prediction

Our latest jaunt through HIV journals looks at a symptom-based scoring system to predict acute HIV, the effect of a person's sex on psychomotor function, and the value of vitamin D supplementation to moderate lipid levels.

This Week in HIV Research: You Don't Know Jak Img

This Week in HIV Research: You Don't Know Jak

Among the research covered this week are fresh findings regarding Jak inhibitors, an exciting experimental class of HIV medications.

This Week in HIV Research: Looking Forward, Looking Back Img
People Who Use Drugs

This Week in HIV Research: Looking Forward, Looking Back

In our final installment of 2017, we intermingle forward-looking research with some retrospective analysis. We begin our four-study tour by joining researchers in Tennessee for an exercise in HIV outbreak prediction.

This Week in HIV Research: The Duracell Batteries of Antiretroviral Therapy Img
News

This Week in HIV Research: The Duracell Batteries of Antiretroviral Therapy

Among this week's selection of four studies, we learn about data from a large study exploring the relative durability of first-line antiretroviral regimens stratified by drug class. (Spoiler alert: Older protease inhibitors don't do so well.)

This Week in HIV Research: In the Care Continuum, Self-Worth Matters Img

This Week in HIV Research: In the Care Continuum, Self-Worth Matters

Among this week's brief tour of recently published studies, we get a reminder about just how deeply mental health can affect an HIV-positive person's clinical care.

HIV diagnosis
News

This Week in HIV Research: Repeat Diagnoses Reveal Gaps in Care

Sobering data regarding linkage to HIV care among women in the U.S.; Latinx HIV incidence inequalities; efficacy of hepatitis C treatment among people with HIV; and a call for frequent STI testing among at-risk people with HIV.

This Week in HIV Research: Quality of Life Is About More Than Viral Suppression Img

This Week in HIV Research: Quality of Life Is About More Than Viral Suppression

This week, we get an important reminder that an HIV-positive person's sense of wellbeing doesn't start and end with an undetectable viral load.